Spots Global Cancer Trial Database for isavuconazole
Every month we try and update this database with for isavuconazole cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas | NCT04548648 | Central Nervous... | Acalabrutinib Isavuconazole | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia | NCT03019939 | Acute Myeloid L... Myelodysplastic... Neutropenia | Isavuconazole | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients | NCT03241550 | Hematological M... | isavuconazonium... isavuconazonium... | 1 Year - 17 Years | Astellas Pharma Inc | |
| Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS) | NCT03964090 | Central Nervous... Secondary Centr... | TEDD-R TEDDI-R Ibrutinib Cytarabine Isavuconazole Methotrexate | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia | NCT03019939 | Acute Myeloid L... Myelodysplastic... Neutropenia | Isavuconazole | 18 Years - | M.D. Anderson Cancer Center | |
| Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma | NCT02203526 | Primary Central... | Isavuconazole TEDDI Rituximab Cytarabine TEDD Ibrutinib (Arms... Methotrexate Ibrutinib (Arm ... Ibrutinib (Arm ... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients | NCT03241550 | Hematological M... | isavuconazonium... isavuconazonium... | 1 Year - 17 Years | Astellas Pharma Inc | |
| A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients | NCT03241550 | Hematological M... | isavuconazonium... isavuconazonium... | 1 Year - 17 Years | Astellas Pharma Inc | |
| Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy | NCT00413439 | Acute Myeloid L... | Isavuconazole | 18 Years - | Basilea Pharmaceutica | |
| Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia | NCT03019939 | Acute Myeloid L... Myelodysplastic... Neutropenia | Isavuconazole | 18 Years - | M.D. Anderson Cancer Center | |
| Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy | NCT00413439 | Acute Myeloid L... | Isavuconazole | 18 Years - | Basilea Pharmaceutica | |
| Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS) | NCT03964090 | Central Nervous... Secondary Centr... | TEDD-R TEDDI-R Ibrutinib Cytarabine Isavuconazole Methotrexate | 18 Years - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
